Finance

Beta
Lists
301509:SHE
Kingchem Liaoning Life Science Co Ltd
CNÂĄ28.26
+1.04%
(+0.29) 1D
Jun 25, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301509...
Open
CNÂĄ27.79
High
CNÂĄ28.28
Low
CNÂĄ26.26
Mkt. cap
3.37B
Avg. vol.
2.10M
Volume
3.67M
Dividend
3.18%
Quarterly dividend
CNÂĄ0.23
Ex-dividend date
Jun 2, 2026
P/E ratio
45.98
52-wk high
CNÂĄ48.60
52-wk low
CNÂĄ25.65
EPS
CNÂĄ0.61
Shares outstanding
120.45M
No. of employees
690
Open
CNÂĄ27.79
High
CNÂĄ28.28
Low
CNÂĄ26.26
Mkt. cap
3.37B
Avg. vol.
2.10M
Volume
3.67M
Dividend
3.18%
Quarterly dividend
CNÂĄ0.23
Ex-dividend date
Jun 2, 2026
P/E ratio
45.98
52-wk high
CNÂĄ48.60
52-wk low
CNÂĄ25.65
EPS
CNÂĄ0.61
Shares outstanding
120.45M
No. of employees
690
News stories
From sources across the web
About Kingchem Liaoning Life Science Co Ltd
CEO-
Employees690
FoundedJun 8, 2009
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
172.06M
139.31M
151.66M
148.11M
Cost of goods sold
113.42M
56.71M
128.00M
85.41M
Cost of revenue
113.42M
56.71M
128.00M
85.41M
Research and development expenses
7.15M
6.86M
14.88M
7.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.85M
34.80M
16.34M
32.26M
Operating expense
43.68M
41.57M
35.76M
42.50M
Total operating expenses
157.10M
98.28M
163.76M
127.90M
Operating income
14.96M
41.03M
-12.10M
20.21M
Other non operating income
-33.26K
-2.84M
2.66M
-6.22M
EBT including unusual items
26.11M
37.76M
790.02K
20.12M
EBT excluding unusual items
23.73M
46.95M
-9.24M
19.28M
Income tax expense
1.76M
6.09M
-588.00K
3.47M
Effective tax rate
6.75%
16.14%
-74.43%
17.26%
Other operating expenses
2.18M
1.52M
2.86M
1.83M
Net income
24.34M
31.67M
1.38M
16.64M
Net profit margin
14.15%
22.73%
0.91%
11.24%
Earnings per share
-
-
-
-
Interest and investment income
9.11M
8.46M
7.48M
5.30M
Interest expense
-1.48K
-16.00K
-149.71K
-8.15K
Net interest expenses
9.11M
8.45M
7.33M
5.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
30.02M
57.26M
2.91M
35.22M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more